Aurora Kinase A and Lung Cancer Subtypes
Author Information
Author(s): Lo Iacono Marco, Monica Valentina, Saviozzi Silvia, Ceppi Paolo, Bracco Enrico, Papotti Mauro, Scagliotti Giorgio V
Primary Institution: Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
Hypothesis
The study investigates the expression of Aurora Kinase A (AURKA) in non-small cell lung cancer (NSCLC) and its correlation with clinico-pathological features.
Conclusion
AURKA over-expression is associated with specific subtypes of lung cancer and tumor de-differentiation.
Supporting Evidence
- AURKA expression was significantly up-modulated in tumor samples compared to matched lung tissue.
- AURKA was principally up-modulated in moderately and poorly differentiated lung cancers.
- No correlation with survival was observed.
Takeaway
This study found that a protein called AURKA is more active in certain types of lung cancer, which might help doctors understand how aggressive the cancer is.
Methodology
Quantitative real-time PCR and immunohistochemistry were used to analyze matched cancer and normal lung tissues from patients.
Limitations
No correlation with survival was observed, and the study did not assess the effects of AURKA inhibition in vivo.
Participant Demographics
64 males and 19 females, median age 67 years (range 40 to 82 years).
Statistical Information
P-Value
p < 0.01
Statistical Significance
p < 0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website